Travere Therapeutics Executives Sell Shares
I'm PortAI, I can summarize articles.
William E. Rote, Chief Research Officer of Travere Therapeutics, sold 60,000 shares at $40.103 each, totaling $2,406,180, and now owns 101,443 shares. Jula Inrig, Chief Medical Officer, sold 15,000 shares at $42.0003 each, totaling $630,004, and now owns 88,787 shares. Both transactions were reported in SEC filings.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments